Frg Family Wealth Advisors LLC Bristol Myers Squibb CO Transaction History

Frg Family Wealth Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $76,576 - $86,822	1,596 New	1,596 $86,000
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $4,793 - $5,676	-70 Reduced 2.34%	2,916 $0
Q2 2022 Jul 11, 2022	SELL	$72.62 - $79.98 $15,613 - $17,195	-215 Reduced 6.72%	2,986 $230,000
Q1 2022 May 06, 2022	SELL	$61.48 - $73.72 $6,148 - $7,372	-100 Reduced 3.03%	3,201 $234,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $458,268 - $534,233	-8,545 Reduced 72.13%	3,301 $206,000
Q3 2021 Mar 02, 2022	SELL	$59.17 - $69.31 $48,223 - $56,487	-815 Reduced 6.44%	11,846 $701,000
Q2 2021 Mar 02, 2022	SELL	$61.91 - $67.42 $155,703 - $169,561	-2,515 Reduced 16.57%	12,661 $846,000
Q1 2021 Mar 02, 2022	SELL	$59.34 - $66.74 $47,472 - $53,391	-800 Reduced 5.01%	15,176 $958,000
Q4 2020 Mar 02, 2022	SELL	$57.74 - $65.43 $8,949 - $10,141	-155 Reduced 0.96%	15,976 $991,000
Q3 2020 Mar 02, 2022	BUY	$57.43 - $63.64 $188,370 - $208,739	3,280 Added 25.52%	16,131 $973,000
Q2 2020 Mar 02, 2022	BUY	$54.82 - $64.09 $704,491 - $823,620	12,851 New	12,851 $756,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Frg Family Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Frg Family Wealth Advisors LLC with notifications on news.